Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: Kevin Podsiadlik who wrote (4571)	11/1/1999 10:17:00 PM
From: Mike M	Read Replies (1) \| Respond to of 10293

That aside, you're essentially admitting, above, that GUMM shopped their study around for a journal that would deliver a publishing commitment within a time frame conducive to maximal PR value. Don't put your words in my mouth. Do you even know when they will publish? I doubt it. In other words, they value quick and timely hype over true journalistic rigor, which most people around here already knew. Kevin, what a ridiculous thing to say. They gave NEJM first crack and plenty of time. You can't force anyone to publish. This clinical deserves to be published (the AJIC just proved that) and there was little point to wait until NEJM was good and ready. If you didn't have your head jammed so far up Wexler's butt you might even acknowledge that. Enjoy while you can, just don't forget to sell at the top. Thanks, I will, enjoy that is. The selling on the other hand is quite a ways away, if ever, for the preponderance of my position. No reason for a philosophical discussion of value here. You weren't listening when the stock was 11....